Sevim Bavbek
YOU?
Author Swipe
View article: Drug hypersensitivity reactions in children in clinical practice: A WAO Statement
Drug hypersensitivity reactions in children in clinical practice: A WAO Statement Open
Drug hypersensitivity reactions (DHRs) in children and adolescents are less common than in adults but can have serious consequences if mismanaged. Mislabeling children as drug-allergic due to incomplete diagnostic evaluations leads to unne…
View article: Effectiveness of Mepolizumab in Patients with OCS-Dependent Severe Asthma: A Real-World Study
Effectiveness of Mepolizumab in Patients with OCS-Dependent Severe Asthma: A Real-World Study Open
View article: Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement
Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement Open
View article: Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper
Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper Open
Antiplatelet drug (APD) therapy is the cornerstone for the prevention of atherosclerotic cardiovascular disease. The main APDs are aspirin and thienopyridines, particularly clopidogrel. These drugs may induce hypersensitivity reactions (HS…
View article: Alert Card for Patients on Biologicals and Immunosuppressives: An <scp>EAACI</scp> Position Paper
Alert Card for Patients on Biologicals and Immunosuppressives: An <span>EAACI</span> Position Paper Open
the EAACI Working Group on Biologicals developed a compact, customizable, wallet- friendly PAC, con- taining concise information for patients and medical staff, treatment details, travel certificate, and physician or hospital contacts
View article: Comparison of three-bag and single-bag protocols in rapid drug desensitization with chemotherapeutic and biological agents
Comparison of three-bag and single-bag protocols in rapid drug desensitization with chemotherapeutic and biological agents Open
View article: Single-Bag Rapid Drug Desensitization: An Alternative to Multiple-Bag Desensitization Protocols
Single-Bag Rapid Drug Desensitization: An Alternative to Multiple-Bag Desensitization Protocols Open
View article: An Overview on Blastocystis spp: The Potential Hidden Cause of Chronic Urticaria
An Overview on Blastocystis spp: The Potential Hidden Cause of Chronic Urticaria Open
View article: Anılarla Tıpta Öncüler-I
Anılarla Tıpta Öncüler-I Open
-
View article: The impact of repeated drug desensitisation on quality of life in drug hypersensitivity
The impact of repeated drug desensitisation on quality of life in drug hypersensitivity Open
Background Measurement of disease‐specific quality of life (QOL) is crucial in evaluating the effects of disease and response to treatment. Patients' efforts to avoid the responsible medication can have a negative impact on the QOL of pati…
View article: Turkish Severe Asthma Program (TSAP)
Turkish Severe Asthma Program (TSAP) Open
View article: Patient-Reported Outcomes in Assessing Disease Activity, Control, and Quality of Life in Chronic Spontaneous Urticaria
Patient-Reported Outcomes in Assessing Disease Activity, Control, and Quality of Life in Chronic Spontaneous Urticaria Open
View article: The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis
The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis Open
This study demonstrates that patients who exhibit ISRs to anti-TNFs produce notably positive results to IDT without maintaining a direct relationship to serum levels of ADAbs.
View article: The use of a long-acting muscarinic antagonist in the treatment of asthma: A tertiary asthma center experience
The use of a long-acting muscarinic antagonist in the treatment of asthma: A tertiary asthma center experience Open
Introduction: We aimed to investigate the frequency and sociodemographic and clinical distinguishing features of asthmatic patients in whom long-acting muscarinic antagonists (LAMA) were added to maintenance therapy in our clinic. Methods:…
View article: Retrospective analysis of rapid drug desensitization with biologic agents: A single center experience
Retrospective analysis of rapid drug desensitization with biologic agents: A single center experience Open
Background Following the increased use of biological agents, a subset of patients experiences hypersensitivity reaction (HSR). We reported our experience with rapid drug desensitization (RDD) to nine biologics (rituximab, infliximab, cetux…
View article: Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST)
Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST) Open
View article: Hypersensitivity Reactions to Taxanes: A Multicenter Study for Outcomes and Safety of Rapid Drug Desensitization
Hypersensitivity Reactions to Taxanes: A Multicenter Study for Outcomes and Safety of Rapid Drug Desensitization Open
PURPOSE: Taxanes can cause hypersensitivity reactions (HSRs), which pose a significant challenge in the treatment of malignancies. Patients who are eligible for rapid drug desensitization (RDD) can continue treatment; however, some patient…
View article: Hypersensitivity reactions to proton pump inhibitors. An <scp>EAACI</scp> position paper
Hypersensitivity reactions to proton pump inhibitors. An <span>EAACI</span> position paper Open
Proton pump inhibitors (PPIs) are invaluable therapeutic options in a variety of dyspeptic diseases. In addition to their well‐known risk profile, PPI consumption is related to food and environmental allergies, dysbiosis, osteoporosis, as …
View article: Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group
Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group Open
Introduction of inhaled corticosteroids (ICS) has been the cornerstone of the long-term management of asthma. ICSs either alone or in combination with long-acting beta-2 agonists have been shown to be associated with favorable asthma outco…
View article: Apples and pears serve the same purpose: Better diagnosis for anaphylaxis
Apples and pears serve the same purpose: Better diagnosis for anaphylaxis Open
View article: Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in adults
Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in adults Open
Background: Hypersensitivity reactions (HSRs) to nonsteroidal anti-inflammatory drugs (NSAIDs) are a significant clinical issue. Several classifications have been proposed to categorize these reactions, including the current European Acade…
View article: Biologics for the treatment of severe asthma: Current status report 2023
Biologics for the treatment of severe asthma: Current status report 2023 Open
Severe asthma is associated with increased use of healthcare services, significant deterioration in the quality of life, and high disease and economic burden on patients and societies. Additional treatments are required for severe forms of…
View article: The profile of severe asthmatics: Results from a specialized asthma clinic
The profile of severe asthmatics: Results from a specialized asthma clinic Open
The high rate of disease control in the patients with severe asthma in the current study demonstrated the importance of targeted individualized therapy with accurate phenotyping in specialized asthma outpatient clinics.
View article: Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey
Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey Open
Whereas most economic evaluations are based on aggregate data, this independent cost-effectiveness analysis using prospective real-world patient-level data suggests that omalizumab in combination with standard of care is cost-effective for…
View article: Peer Review Report For: Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 1; peer review: 1 approved with reservations]
Peer Review Report For: Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 1; peer review: 1 approved with reservations] Open
View article: Comparison of two diagnostic criteria in the diagnosis of anaphylaxis in a tertiary adult allergy clinic
Comparison of two diagnostic criteria in the diagnosis of anaphylaxis in a tertiary adult allergy clinic Open
View article: Referee report. For: Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 2; peer review: 1 approved]
Referee report. For: Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 2; peer review: 1 approved] Open
View article: Anaphylaxis is rare due to CoronaVac in a population of healthcare workers
Anaphylaxis is rare due to CoronaVac in a population of healthcare workers Open
Background CoronaVac, the first coronavirus disease 2019 vaccine administered in our country, was found safe in clinical trials. Objective We aimed to reveal the rate and features of CoronaVac vaccine-associated allergic reactions among va…
View article: Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience
Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience Open
The incidence of COVID-19 among patients with asthma and urticaria on mepolizumab and omalizumab was higher compared to studies from other countries. The disease course appeared mild in patients receiving long-term biological therapy.
View article: Can dose reduction be made in patients with allergic bronchopulmonary aspergillosis receiving high-dose omalizumab treatment?
Can dose reduction be made in patients with allergic bronchopulmonary aspergillosis receiving high-dose omalizumab treatment? Open
Background. Allergic bronchopulmonary aspergillosis (ABPA) is an endotype of severe asthma which frequently needs biologics for their steroid sparing effect. We aimed to evaluate the outcomes of reducing the omalizumab dose in patie…